Waystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
Follow WAY
Alert me
Waystar Holding Corp. (WAY) Revenue growth
Waystar Holding Corp.'s revenue growth over the twelve months to 30 September 2026 was 21.4%, up 4.9 percentage points from fiscal 2025 (16.5%). That is above the Health Information Services industry median of 6.48% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 16.5% | (2.78) |
| FY2024 | 19.3% | 7.06 |
| FY2023 | 12.2% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 21.2% | 3.10 |
| Jun 2026 | 18.1% | (4.29) |
| Mar 2026 | 22.4% | (1.95) |
| Dec 2025 | 24.4% | 12.46 |
| 5 more quarters | Free account |
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| HNGE Hinge Health Inc. compare | 58.8% |
| HTFL Heartflow, Inc. compare | 42.8% |
| TEM Tempus AI, Inc. compare | 36.6% |
| BTSG BrightSpring Health Services, Inc. compare | 26.0% |
| WAY Waystar Holding Corp. | 21.4% |
| PRVA Privia Health Group, Inc. compare | 19.2% |
| HQY HealthEquity, Inc. compare | 7.34% |
| DOCS Doximity, Inc. compare | 6.48% |
| SDGR Schrodinger, Inc. compare | 4.77% |
| Health Information Services industry median | 6.48% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on WAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Beneish M-score
- The full statement